Comerica Securities’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-176
| Closed | -$6.24K | – | 853 |
|
|
2022
Q4 | $6.24K | Buy |
+176
| New | +$6.24K | ﹤0.01% | 1092 |
|
|
2020
Q4 | – | Sell |
-9,350
| Closed | -$446K | – | 485 |
|
|
2020
Q3 | $446K | Sell |
9,350
-1,667
| -15% | -$79.5K | 0.04% | 293 |
|
|
2020
Q2 | $569K | Sell |
11,017
-2,101
| -16% | -$109K | 0.05% | 249 |
|
|
2020
Q1 | $632K | Sell |
13,118
-798
| -6% | -$38.4K | 0.07% | 219 |
|
|
2019
Q4 | $826K | Buy |
13,916
+903
| +7% | +$53.6K | 0.08% | 229 |
|
|
2019
Q3 | $702K | Buy |
13,013
+523
| +4% | +$28.2K | 0.07% | 239 |
|
|
2019
Q2 | $625K | Buy |
12,490
+828
| +7% | +$41.4K | 0.07% | 239 |
|
|
2019
Q1 | $617K | Buy |
11,662
+1,275
| +12% | +$67.5K | 0.07% | 239 |
|
|
2018
Q4 | $502K | Buy |
10,387
+261
| +3% | +$12.6K | 0.07% | 247 |
|
|
2018
Q3 | $515K | Sell |
10,126
-1,246
| -11% | -$63.4K | 0.06% | 270 |
|
|
2018
Q2 | $580K | Buy |
11,372
+486
| +4% | +$24.8K | 0.07% | 248 |
|
|
2018
Q1 | $540K | Sell |
10,886
-1,207
| -10% | -$59.9K | 0.07% | 254 |
|
|
2017
Q4 | $543K | Buy |
12,093
+955
| +9% | +$42.9K | 0.07% | 257 |
|
|
2017
Q3 | $571K | Buy |
11,138
+2,550
| +30% | +$131K | 0.08% | 238 |
|
|
2017
Q2 | $467K | Buy |
8,588
+1,546
| +22% | +$84.1K | 0.07% | 256 |
|
|
2017
Q1 | $371K | Buy |
7,042
+1,177
| +20% | +$62K | 0.06% | 283 |
|
|
2016
Q4 | $282K | Sell |
5,865
-1,946
| -25% | -$93.6K | 0.12% | 183 |
|
|
2016
Q3 | $421K | Sell |
7,811
-395
| -5% | -$21.3K | 0.18% | 126 |
|
|
2016
Q2 | $445K | Buy |
8,206
+3,352
| +69% | +$182K | 0.22% | 105 |
|
|
2016
Q1 | $246K | Buy |
4,854
+376
| +8% | +$19.1K | 0.13% | 161 |
|
|
2015
Q4 | $226K | Buy |
4,478
+256
| +6% | +$12.9K | 0.14% | 160 |
|
|
2015
Q3 | $203K | Buy |
+4,222
| New | +$203K | 0.12% | 175 |
|